Harvard Business Review

MARCH 11, 2014

That is, why bother trying to innovate if no matter what they do, large companies can no longer maintain a sustainable advantage and their life spans are just getting shorter and shorter? In these markets if existing companies don’t rise to the innovation challenge, no one will. “Why bother?”.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

MARCH 28, 2012

This ongoing struggle raises an issue that is endemic in such acquisitions: In search of innovation, big companies often buy other companies whose most innovative days are almost at an end. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Strategy Driven

MAY 12, 2021

Drug Research —The applications for drug design and biotechnology using 3D displays can be exponential. With 3D tomosynthesis, doctors can pinpoint the size and location of cancer tumors in dense tissue; they can detect abnormalities earlier and better see small tumors because the images are clearer and have greater contrast.

Technology 105

Technology Content Video Globalization 105

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And biotechnology and medical devices are among the leading areas for venture capital funding. In all of these settings, physicians and patients are happy.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

OCTOBER 1, 2014

The implicit axiom here is that robust companies that have sustained and grown over the longer term are somehow less innovative. And Alibaba is a 16 year-old company, and no one is claiming it is sluggish or un-innovative.) Economy Entrepreneurship Innovation'

Entrepreneur 11

Entrepreneur Real Estate Biotechnology Innovation 11

Harvard Business Review

JULY 11, 2018

However, young people are less common in other industries such as oil and gas or biotechnology, where the average age is closer to 47. Steve Jobs and Apple introduced the company’s most profitable innovation, the iPhone, when Jobs was 52. In software startups, the average age is 40, and younger founders aren’t uncommon.

Succession 15

Succession IPO Entrepreneur Biotechnology 15

Harvard Business Review

OCTOBER 26, 2011

Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Click on the table below to see at full size.).

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

MARCH 8, 2013

government, which through DARPA and other initiatives stands out worldwide for its astoundingly positive track record in funding true innovation. It is not by accident that the National Institutes of Health spends $31 billion a year on supporting innovation in biotechnology and pharmacology. Consider Apple.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Innovation 8

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Finding ideas is never the problem — initially. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

MARCH 1, 2012

Second, the bigger CMOs tend to have specialized skills and knowledge that can help their partners innovate. For example, in biotechnology, a field in which the U.S. innovation" typically means just one thing to people: novel gadgets. Third, they create jobs — really good, high-paying jobs. In the U.S.,

Contract Manufacturing 9

Contract Manufacturing Offshoring Supply Chain Biotechnology 9

Harvard Business Review

MAY 2, 2011

Another CEO of a fast-growing biotechnology venture, a Chinese-American entrepreneur, added that he wanted his company to be perceived as American rather than as Chinese. "Most technology ventures in China are of the C2C variety, i.e., Copy-To-China.

Globalization 14

Globalization Marketing Venture Capitalist Biotechnology 14

Harvard Business Review

JUNE 4, 2018

’s “once unchallenged preeminence in commerce, industry, science, and technological innovation is being overtaken by competitors throughout the world.” .” This groundbreaking report, commissioned by President Ronald Reagan, concluded that the U.S.’s ” Unfortunately, this goal hasn’t been met. .

Education 8

Education Company Biotechnology Human Capital 8

Harvard Business Review

MARCH 2, 2012

French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology. America fosters risk-taking and innovation by entrepreneurs who become global leaders. Nestle, Unilever, and Novartis have several business units based in the U.S.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Strategy Driven

NOVEMBER 18, 2019

There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. Technology is innovation and looks likely to form the foundation for much of our society for the foreseeable future. Technology.

Health Care 67

Health Care Biotechnology Energy Insurance 67

Harvard Business Review

OCTOBER 16, 2013

If we want to have a strong economy, we need to make sure we’re tilting the playing field in favor of entrepreneurs that are trying to challenge the status quo, innovate, create new products and services, disrupt existing industry, usher in a new way. They are fueling innovation and growth. A restaurant might start.

Venture Capitalist 10

Venture Capitalist Company Transportation Biotechnology 10

Harvard Business Review

JUNE 16, 2016

The Institute for Applied Cancer Science at MD Anderson (IACS) is exploring revolutionary new cures and the National Network for Manufacturing Innovation (NNMI) is working to revive the US production capacity. Innovating the Innovation Process. A National Innovation Ecosystem.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

MARCH 13, 2012

Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa? Wouldn't it make sense to test drive state-owned banks elsewhere to see if they could help support local industries? Our 50 states have been called laboratories of democracy.

Real Estate 10

Real Estate Biotechnology Tourism Banking 10

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

The Horizons Tracker

DECEMBER 30, 2019

They raised more money and were acquired at higher valuations; however, they did not innovate more. If it is a venture capital-oriented IT, hardware or biotechnology company, this destination might be Silicon Valley.”. This reflects the strength of the US entrepreneur ecosystem compared to Israel.”. Movement of talent.

Biotechnology 56

Biotechnology Human Capital Travel Entrepreneur 56

Harvard Business Review

APRIL 19, 2016

has been an innovation superpower. In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. vincent tsui FOR HBR. Since World War II, the U.S. Google got its start from a federal grant.

Innovation 8

Innovation Company Competitive Advantage White Paper 8

Harvard Business Review

FEBRUARY 3, 2015

Make you more innovative. Uzzi and another colleague, Jarrett Spiro, also discovered that this pattern held across sectors as disparate as the Broadway mu­sical industry and biotechnology. The sidebar “The Innovator’s Network Dilemma” presents convincing data that bears out this observation.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

NOVEMBER 29, 2016

Innovating for Value in Health Care. It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing. Insight Center. Sponsored by Medtronic. Exploring cutting edge ways to lower costs and improve quality.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

MARCH 5, 2012

This tight connection between R&D, innovation, and production is present in sectors like biotechnology, advanced materials, and nanotechnology. Manufacturing is a critical component of the American ecosystem for innovation and can be an important part of the knowledge economy. If we lose manufacturing, R&D eventually follows.

Health Care 9

Health Care Biotechnology Policies Industry 9

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., And what did they say was their biggest concern? Not competitive threats. Not rising costs. chemicals, metals & mining, paper & forest products).

Talent Management 8

Talent Management Company Management Telecommunications 8

Harvard Business Review

MARCH 30, 2017

We worked with a startup biotechnology company. It cannot be predicted or easily orchestrated. The very fact that it is an internal difference requires us to work hard to surface it and harness the benefits. When its R&D team members tried our strategy execution task, they performed terribly.

Diversity 8

Diversity Team Biotechnology Execution 8

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Customers Innovation Technology'

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. The United States is home to some of the key pioneers of Technik whose innovations help society adapt to the future. It pledges $1.5

First-mover Advantage 9

First-mover Advantage GDP Technology Biotechnology 9

Harvard Business Review

FEBRUARY 24, 2017

Not only did his wife invest between $610,000 and $1.5

Conflict of Interest 8

Conflict of Interest Committee Collins Politics 8

Harvard Business Review

NOVEMBER 9, 2016

To cope with the cyclical variations of copper prices, the industry made an innovative leap into the health care sector, a move that represents a clear departure from the commodity trap. But the regional steel industry’s leaders minimized exposure to price volatility by focusing on product and process innovations.

Cooper 14

Cooper Long-term Industry Health Care 14